Oscar Health IncOSCR
▼ NegativeCapitalrelevance
Stock fell despite Q2 earnings beat, likely due to concerns about utilization trends and guidance.
Impact on stocks 1
Financials
Oscar Health IncOscar Health reported second-quarter results that significantly exceeded Wall Street expectations, yet its stock declined following the earnings call. Revenue reached $4.88 billion, a 70.4% year-over-year increase and 2.9% above analyst estimates of $4.74 billion, while adjusted EPS of $1.10 far surpassed the $0.38 consensus. Adjusted EBITDA came in at $415.3 million versus the $170.9 million expected, and operating margin improved to 8% from negative 8% a year earlier. CEO Mark Bertolini attributed the performance to disciplined pricing, technology-driven cost efficiencies, and strong execution in the individual health insurance market, with membership up 46% and administrative cost ratios at historic lows. During the call, analysts questioned management on outpatient utilization trends, visibility into medical loss ratio guidance, rate positioning for 2027, the ICHRAx partnership, and the financial impact of CMS eligibility reviews on member disenrollment.
Oscar Health IncStock fell despite Q2 earnings beat, likely due to concerns about utilization trends and guidance.